Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice-Reference-Cited by-同舟云学术

Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice

Published:2015-12 Issue:12 Volume:135 Page:3060-3067
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Hou Yingping,Guey Lin T.,Wu Timothy,Gao Robert,Cogan Jon,Wang Xinyi,Hong Elizabeth,Vivian Ning Weihuang,Keene Douglas,Liu Nan,Huang Yan,Kaftan Craig,Tangarone Bruce,Quinones-Garcia Igor,Uitto Jouni,Francone Omar L.,Woodley David T.,Chen Mei

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference47 articles.

1. The phagokinetic tracks of 3T3 cells;Albrecht-Buehler;Cell,1977

2. Special lectures in haemophilia management;Batorova;Haemophilia,2010

3. Enzyme replacement in Gaucher disease;Beutler;PLoS Med,2004

4. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture;Boyce;J Invest Dermatol,1983

5. Type VII collagen, anchoring fibrils, and epidermolysis bullosa;Burgeson;J Invest Dermatol,1993

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa;Journal of Applied Genetics;2024-03-09

2. EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening;Journal of Experimental & Clinical Cancer Research;2024-01-10

3. Epidermal or Dermal Collagen VII Is Sufficient for Skin Integrity: Insights to Anchoring Fibril Homeostasis;Journal of Investigative Dermatology;2023-11

4. Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2023-11

5. EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening;2023-10-09